Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)

Machado, Daisy Maria; Fernandes, Silvana Cláudia; Succi, Regina Célia de Menezes; Freire, Wilton Santos; Pannuti, Cláudio Sérgio; Gouveia, Aída Barbosa; Levi, José Eduardo; Diaz, Ricardo Sobie.
Rev. Inst. Med. Trop. Säo Paulo ; 47(1): 1-5, jan.-fev. 2005. tab, graf
Artigo em Inglês | LILACS | ID: lil-393336

Documentos relacionados

  1. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey.
  2. Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
  3. HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.
  4. Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells.
  5. Analysis of mutational history of multidrug-resistant genotypes with a mutagenetic tree model.
  6. HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting.
  7. HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
  8. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
  9. Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
  10. Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.